Sampige Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
- Paid Up Capital ₹ 1.70 Cr
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.70 Cr
- Revenue Growth -10.21%
- Profit Growth -3222.16%
- Ebitda -89.52%
- Net Worth -8.22%
- Total Assets -7.53%
About Sampige Diagnostic Centre
Sampige Diagnostic Centre Private Limited (SDCPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2012 and has a history of 12 years and four months. Its registered office is in Hassan, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹2.70 Cr.
Srivatsa Kumar and Madapura Devaprasad serve as directors at the Company.
Company Details
- Location
Hassan, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110KA2012PTC066232
- Company No.
066232
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sampige Diagnostic Centre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madapura Devaprasad  | Director | 04-Sep-2021 | Current |
| Srivatsa Kumar | Director | 10-Oct-2012 | Current |
Financial Performance of Sampige Diagnostic Centre.
Sampige Diagnostic Centre Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 10.21% decrease. The company also saw a substantial fall in profitability, with a 3222.16% decrease in profit. The company's net worth dipped by a decrease of 8.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sampige Diagnostic Centre?
In 2021, Sampige Diagnostic Centre had a promoter holding of 65.88% and a public holding of 34.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.70 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2016 | Others | ₹2.70 Cr | Open |
How Many Employees Work at Sampige Diagnostic Centre?
Unlock and access historical data on people associated with Sampige Diagnostic Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sampige Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sampige Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
